JPMorgan Chase Faces Regulatory Headwinds Amid Overvaluation Concerns
JPMorgan Chase & Co (NYSE: JPM) is at the center of a regulatory dispute involving the Federal Reserve’s proposed adjustments to capital surcharges for globally significant U.S. banks.
The Fed seeks to recalibrate risk sensitivity by modifying how short-term wholesale funding is assessed, potentially reshaping capital relief outcomes across major banks.
JPMorgan's current Price-to-Sales ratio of 4.97x is significantly elevated relative to its historical median of 3.51x over the past five years, suggesting investors are pricing in expectations of continued revenue growth and operational resilience.
The GF Value™ metric estimates JPMorgan’s intrinsic value at $314.49 per share, which is approximately 12.9% below its current market price of $355.00, indicating modest overvaluation.